Global beauty major L'Oréal has signed a long-term license agreement with high-end Italian fashion house Prada to develop a luxury beauty line it says will be an ‘ideal complement’ to its Luxe brands.
China looks set to ban the sale of repackaged cosmetics, according to industry commentators, a move which will shut down the widespread practice of repackaging and remarketing products in the country.
US-based International Stem Cell Corporation (ISCO) has signed a license agreement for Japan-based Rohto Pharmaceuticals that aims to manufacture products for the medical and cosmetics categories.
A new Drugs and Cosmetics (Amendment) Bill has been introduced by the Indian government that includes the establishment of a Central Drugs Authority as an overarching body to regulate cosmetics.
Utah-based Nu Skin has received official notification from China's Ministry of Commerce of its approval to commence direct selling activities in five additional provinces and 30 districts.
IP Resources agrees on Hong Kong licensing deal for stem cell skin care US-based IP Resources has signed a licensing agreement in Hong Kong and Macau for its new stem cell skin care product that aimed at positioning it in the Asia Pacific market.
Global beauty company, Coty, has announced it has signed a licensing agreement with Calvin Klein to develop and market a new color cosmetics line, due to be launched in 2012.
Migami, a US-based company that has made its name developing and
testing clean air technology, has acquired assets in the company
Innovay, giving it a new direction purchasing licensing rights for
cosmetic and pharmaceutical products.
US-based Helix BioMedix and American Global Health Group (AGHG)
have signed a license agreement for the inclusion of certain Helix
peptide technology for AGHG skin care products that are presently
under development and expected to...
Inter Parfums has announced a worldwide license agreement with
Lanvin to create, develop and distribute fragrance lines under the
Lanvin brand name over the next 15 years.